Work

The potential of (177Lu)-PSMA-617 in the first-line combination therapy with enzalutamide for metastatic castration-resistant prostate cancer: clinical insights from the ENZA-p trial

Year: 2025

Type: article

Source: Chinese Clinical Oncology

DOI: 10.21037/cco-25-65

Authors: Renning Zheng, Stephen J. Freedland, Anthony T. Nguyen

Institutions: Cedars-Sinai Medical Center, Tsinghua University, Durham VA Health Care System, Durham VA Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4415649453

FWCI:

Cites:

Cited by:

Related to: 10